OTC Markets OTCQB - Delayed Quote USD
Hemostemix Inc. (HMTXF)
0.0640
0.0000
(0.00%)
As of April 24 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-332.5740
-1,419.7610
-6,101.7450
-3,477.6610
-5,975.0270
Investing Cash Flow
--
--
--
171.1160
--
Financing Cash Flow
18.3120
1,439.4310
6,018.0460
3,268.0390
6,208.9140
End Cash Position
63.3270
155.4160
135.7460
219.4450
257.9510
Issuance of Capital Stock
18.3120
1,504.7360
3,451.9480
839.9230
8,765.2940
Issuance of Debt
--
--
2,750
2,500
2,069.2790
Repayment of Debt
--
--
--
-175
-3,918.8000
Free Cash Flow
-332.5740
-1,419.7610
-6,101.7450
-3,477.6610
-5,975.0270
12/31/2020 - 1/7/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RENB Renovaro Inc.
0.3778
+1.34%
ONC BeiGene, Ltd.
247.24
-3.48%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8215
-8.72%
APLT Applied Therapeutics, Inc.
0.3989
+0.15%
BMEA Biomea Fusion, Inc.
2.2600
-1.74%
BHVN Biohaven Ltd.
19.82
-15.32%
GERN Geron Corporation
1.4250
+0.35%
REGN Regeneron Pharmaceuticals, Inc.
598.32
-0.24%
VRTX Vertex Pharmaceuticals Incorporated
491.51
-0.20%
MRNA Moderna, Inc.
27.31
-0.29%